Rezulin (troglitazone) for Type II diabetes
March 1997
Rezulin (troglitazone) for Type II diabetes will be out soon. Parke-Davis is launching it this month in the U.S...possibly later this year in Canada.
This is the first drug in a new class...called "glitazones." These drugs are very useful...they reduce insulin resistance.
Troglitazone stimulates the uptake of glucose into skeletal muscle cells...and decreases glucose production in the liver.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote